CytRx raises $22.5 million in follow-on

CytRx Corp. (NASDAQ:CYTR) raised $22.5 million through the sale of 10 million shares at $2.25 in a follow-on underwritten by Aegis Capital and H.C. Wainwright. CytRx's aldoxorubicin is in a Phase IIb ...